79320193 - XCUBE

Information

  • Trademark
  • 79320193
  • Serial Number
    79320193
  • Filing Date
    February 25, 2021
    5 years ago
  • Transaction Date
    July 09, 2025
    a year ago
  • Status Date
    July 08, 2025
    a year ago
  • Location Date
    July 08, 2025
    a year ago
  • Status Code
    641
  • Current Location
    TMEG LAW OFFICE 103
    Employee Name
    IN, SUNG
  • Attorney Name
    Anna Kurian Shaw
    Law Office Assigned Location Code
    L30
  • Owners
Mark Drawing Code
4
Mark Identification
XCUBE
Case File Statements
  • GS0091: Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; none of the foregoing in connection with HVAC systems or components thereof
  • PM0001: X CUBE
  • GS0351: Compilation of statistical data and models with respect to cancer treatment and cancer diagnosis
  • GS0441: Medical and pharmaceutical consultancy services
  • GS0421: Computer programming in the medical, pharmaceutical and biotechnological field; database design in the medical, pharmaceutical and biotechnological field; maintenance of database software in the medical, pharmaceutical, and biotechnological field; programming of software for importing and managing data in the medical, pharmaceutical, and biotechnological field; information technology [IT] consulting services for the pharmaceutical and healthcare industries; computer programming for data processing; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; providing scientific molecular and genomic information for medical and clinical research, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology; none of the foregoing in connection with HVAC systems or components thereof
Case File Event Statements
  • 9/21/2021 - 4 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/16/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/20/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/21/2021 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/22/2021 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/24/2021 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/7/2021 - 4 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR
  • 10/13/2021 - 4 years ago
    8 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/14/2021 - 4 years ago
    9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 11/8/2021 - 4 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 11/8/2021 - 4 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/29/2021 - 4 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/6/2022 - 4 years ago
    13 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 5/10/2022 - 4 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 5/12/2022 - 4 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/12/2022 - 4 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/13/2022 - 4 years ago
    17 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/13/2022 - 4 years ago
    18 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/13/2022 - 4 years ago
    19 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/7/2022 - 3 years ago
    20 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 11/2/2022 - 3 years ago
    21 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/2/2022 - 3 years ago
    22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/2/2022 - 3 years ago
    23 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/2/2022 - 3 years ago
    24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/2/2022 - 3 years ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/28/2022 - 3 years ago
    26 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 1/30/2023 - 3 years ago
    27 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/30/2023 - 3 years ago
    28 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/30/2023 - 3 years ago
    29 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/22/2023 - 3 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 2/27/2023 - 3 years ago
    32 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 3/14/2023 - 3 years ago
    33 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 4/20/2024 - 2 years ago
    38 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 2/22/2023 - 3 years ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/25/2023 - 2 years ago
    34 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 3/25/2024 - 2 years ago
    35 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 3/29/2024 - 2 years ago
    36 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/29/2024 - 2 years ago
    37 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 11/15/2024 - a year ago
    41 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 11/15/2024 - a year ago
    40 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 11/15/2024 - a year ago
    39 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/16/2025 - a year ago
    42 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 7/8/2025 - a year ago
    43 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/8/2025 - a year ago
    44 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/8/2025 - a year ago
    45 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN